SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The Financial Collapse of 2001 Unwinding -- Ignore unavailable to you. Want to Upgrade?


To: kingfisher who wrote (7619)6/2/2021 2:30:30 AM
From: elmatador2 Recommendations

Recommended By
gg cox
kingfisher

  Respond to of 13800
 
Highest price: $51,783.33 per Metric Ton (May 2007)

Price as of April 2021: $16,406.66 per Metric Ton

Nickel is derived from both mining ore and recycling. The resulting metal is used in hundreds of thousands of everyday products. One of the biggest indicators that determine nickel price increases is demand from China. The country depends on nickel for everything from batteries to stainless steel products, regularly requiring more than half of the global nickel supply.

Highest price ever for every major commodity
By Liz Barrett Foster

Stacker researched the highest prices on record for every major commodity using the Federal Reserve's Economic Data database. See what affects prices beyond supply and demand.

https://www.gwinnettdailypost.com/multimedia/highest-price-ever-for-every-major-commodity/collection_cdaad580-350b-58de-88e6-204137ae4d4a.html#14



To: kingfisher who wrote (7619)6/2/2021 3:04:55 AM
From: elmatador1 Recommendation

Recommended By
kingfisher

  Respond to of 13800
 
Chinese Factories Delay New Orders as Costs Rise, Risking Global Supply Shortages

Higher raw-material prices and a lack of workers are forcing more manufacturers to slow production, stoking fears of inflation

By Stella Yifan Xie June 1, 2021 6:30 am ET

HONG KONG—Buffeted by rising costs, some Chinese manufacturers are refusing to accept new orders or are even considering shutting down operations temporarily—moves that could put more strain on global supply chains and cause more inflation.

Surging raw-material prices and a shortage of workers have pinched smaller Chinese manufacturers, including many that sell their products to the U.S. and other Western markets. While many have passed their higher costs on to overseas buyers, the pain is so severe at some manufacturers that they are finding it hard to raise prices enough to make up the difference. Others don’t want to risk losing business to competitors. Many are now looking for other solutions to avoid losing money.

Zhongshan Xiliwang Electrical Appliances Co., a kitchen ventilator producer based in southern China, told clients in mid-May that it would stop accepting new orders temporarily and urged customers to wait for two weeks before negotiating prices, given their volatility.

The company has been operating at a loss since April, in part because of a substantial increase in prices for metals, glasses and switches, it said in its notice to buyers.
Xing Jialiang, the owner of a glass factory in Zhongshan, says his company is also running out of good options. It has raised prices by about 5% so far this year, but that hasn’t been enough to keep up with a 10% increase in costs, he said.

ELMAT: And then this
Costs were pushed higher in part because Chinese authorities shut down or limited production at some high-polluting plants, Mr. Xing said, including those in glass manufacturing, which is energy-intensive and emits large amounts of carbon dioxide. China has vowed to achieve carbon neutrality by 2060.

wsj.com



To: kingfisher who wrote (7619)6/3/2021 12:35:34 PM
From: elmatador1 Recommendation

Recommended By
kingfisher

  Respond to of 13800
 
Farm Capital Expenditures Remain Depressed
In 2019, the USDA expects farm capital expenditures will amount to $30 billion (Figure 1). There are a few ways to look at this level. On one hand, it is a dramatic decline from the nearly $50 billion seen in 2014.

On the other hand, today’s levels are back to those experienced in the early 2000s, when farm incomes were more stable. One question is whether we should expect to see capital expenditures climb much higher or stabilize at near the current levels?

Figure 1. Real (2019 USD) Capital Expenditures, Excluding Operator Dwellings, 1970-2019f.



Farm Capital Expenditures Stabilizing?
aei.ag



To: kingfisher who wrote (7619)6/15/2021 5:59:31 AM
From: elmatador1 Recommendation

Recommended By
kingfisher

  Respond to of 13800
 
This is a market distortion at work:
China, instead of creating a middle class, it uses its wealth to subsidise its industry to sell cheap products to foreign countries that buy them cheap.
This is steel which the world has an over-capacity estimated by the OECD in 700 million tons.




To: kingfisher who wrote (7619)12/15/2021 2:35:39 AM
From: elmatador1 Recommendation

Recommended By
kingfisher

  Respond to of 13800
 
UK just removed the travel ban on 11 African countries.


Let's watch the vaccine stocks' debacle once EU and US remove the travel bans too.


That pulls the floor under the vaccine stocks that got a boost on "Omicron concerns"

Vaccine makers were betting on an "Omicron concerns"

The whole vaccine circus assembled collpases as there is no more room to vaccinate people.
  • People who needed a vaccinae are long ago vaccinated.
  • People who thought they need the shot idem
  • After all that, the Law of the Big Numbers kicks in: For every new shot sold there is a huge effort just to sell a shot. No longer worse the effort

Covid vaccine makers' stocks soar on Omicron variant concerns




By Paul R. La Monica, CNN Business

Updated 1947 GMT (0347 HKT) November 29, 2021

Fears about the Omicron variant of Covid-19 rattled the world's financial markets Friday and early Monday morning. But shares of the major coronavirus vaccine makers were getting a boost from the latest pandemic jitters.

Moderna ( MRNA) soared more than 20% during Black Friday's abbreviated session of trading on Wall Street and were up another 10% Monday, too.
BioNTech ( BNTX) surged 14% Friday and were up 3% Monday while the European drug maker's vaccine partner, Big Pharma leader Pfizer ( PFE), gained 6% Friday but fell a bit Monday.

Shares of Novavax ( NVAX), another company that is seeking approval from the United States' Food and Drug Administration for its Covid vaccine, were up 9% Friday but gave back a big chunk of those gains Monday, falling 8%.

The stocks of two other vaccine manufacturers — Johnson & Johnson ( JNJ) and AstraZeneca ( AZN) — moved only modestly Friday and Monday.

Investors are hoping that the major vaccine makers will be able to quickly update their Covid vaccines so that it can offer protection for the Omicron variant.

Moderna said Friday that it "will rapidly advance an Omicron-specific booster candidate" while Pfizer has stressed that it could hopefully have an update of its vaccine ready in 100 days if Omicron proves to be resistant to its current vaccine.